SensDx received the Good Design 2020 New Technologies award for Flu SensDx – a mobile diagnostic platform for pathogen detection!Read more
A significant challenge ahead of us!
Although we are a young startup, we are participating in the Implementation Doctorate Program. Five of our employees have just started their Ph.D. studies in SensDx and Wroclaw University of Science and Technology and Wroclaw University of Environmental and Life Sciences. The studies include new technological problems which we are going to solve.Read more
We have opened another drive through diagnostic point with tests for COVID-19 operated by Centrum Medyczne Sonokard!
Since September 22nd, 2020, you can test yourself for the SARS-CoV-2 virus in Kobierzyce. The diagnostic point is located on the parking lot of Twój Lekarz sp.p. NZOZ on Tuesdays and Fridays from 9:30 to 11:30.Read more
The number of people infected with coronavirus grows every day, and so does the need for fast and precise tests for virus detection. The derivative of the occurred situation resulted in creating our SARS-CoV-2 SensDx test to detect the SARS-CoV-2 virus in throat swabs.Read more
It’s on! A drive through diagnostic point that performs tests for the SARS-CoV-2 virus’s presence using our digital diagnostic platform SARS-CoV-2 SensDx.
Take the test and get the result in 15 minutes!
You can find us at ul. Bierutowska 57-59 (Wrocław Business Park 3).
Sign up here: testprzesiewowy.pl
The first diagnostic test for COVID-19 and influenza A / B, giving a reliable result in 6 minutes, is launched by the Polish company SensDx. A quick test detects the presence of the virus in a patient even at a very early stage of the infection with sensitivity at the level of a genetic test. This method can contribute effectively to pandemic control.Read more
SensDx has received positive grant recommendation from Agency of Medical Research for research and mass production implementation of SARS-CoV-2 diagnostics.Read more
SensDx and the team of prof. Krzysztof Pyrc from Małopolska Centre of Biotechnology of the Jagiellonian University undertook joint activities to develop an ultrafast diagnostic test for SARS-CoV-2 virus (COVID-19).Read more
We are growing! Our digital diagnostic platforms for influenza virus detection are now available in over 100 medical facilities across Poland!Read more
We are proud to announce that we obtained ISO 13485:2016 certificate – one of the most strict and demanding! It covers design and development, manufacture and distribution of in vitro diagnostic rapid tests used in the detection of the upper respiratory tract infections. This stands for the quality of our products and shows the effort we put in product development.Read more
SensDx was recommended in the first call of the Polish Investment & Trade Agency (PAIH) project – Polish Technological Bridges! We are in the group of 50 small and medium Polish #enterprises with the highest number of points. We will receive comprehensive, including financial and substantive support in developing and implementing expansion strategy for Australia’s and India’s market.Read more
dr Dawid Nidzworski – CTO of SensDx is among the 25 most Creative in the ranking of 50 Most Creative in Business by Brief magazine. Results were announced during the Grand Final Gala of the 9th edition of this Competition at the Indigo Hotel in Warsaw.Read more
Tomasz Gondek – CEO of SensDx and Tomasz Nawrocki – CEO of Synoptis Industrial confirmed partnership on production activity of innovative flu diagnostic test. Tomasz Nawrocki said: “This is a great start of long and successful cooperation delivering world first flu diagnosis device to the market. I’m thrilled Synoptis is part of this unique project and will be part if it’s international commercial success.”Read more
SensDx SA, together with the Institute of Biotechnology and Molecular Medicine (IBMM), was a partner of the START program. We funded one of the scholarships during the ceremony of giving scholarships to the START program of the Foundation for Polish Science is in progress. Dawid Nidzworski – CTO SensDx and the President of IBMM represented us at the event. Congratulations to everyone who has been awarded!Read more
Katarzyna Pala, BEng, PhD – Business Development Director in an interview for Top 500 Innovators.Read more
SensDx S.A. was one among exhibitors at T4M – Technology for Medical Devices. It is a combination of a trade fair, forums, workshops and networking, that attracts exhibitors from all important areas of medical technology from around the world, such as FANUC Germany, Citizen Machinery Europe, Gindele, FOBA Laser Marking + Engraving Alltec or XIMEA. Over 55 new companies will present their innovations at the pitching stage, including SensDx.Read more
We were at the 3rd Medical Devices Conference in Boston (World BI). This is one of the largest conferences in the USA dedicated to medical devices, it shows what’s happening in the industry and discusses current trends. Tomasz Gondek presented our diagnostic test.Read more
Stefan Müllner, PhD – the long time CEO of the autoimmune diagnostic specialist Protagen AG, Dortmund, Germany, with strong industrial background from management and board positions in the pharma (Hoechst, Aventis), biotech (Maltagen, Phenion, BiotEx, SusTech) consumer products (Henkel) and venture capital industries (fundamenta Capital) and has joined the Advisory Board of SensDx SA.Read more
Our CEO – Tomasz Gondek presented “SensDx – case study” at the Congress Center in the Wrocław University of Technology. He talked about creating our diagnostic test and the recognizable startup in Europe. The organizers of the event were the Ministry of Science and Higher Education, National Center for Research and Development, Wrocław University of Technology and Łukasiewicz Research Network – PORT Polish Center for Technology Development.Read more
We were one of the only nine European companies at DMEA – the largest event in Europe for the medicalindustry in the Digital Health area! We presented our diagnostic test, we met the industry, we participated in symposia, we visited the Trade Fair. We also presented our company and product to an international assembly of experts along with Kasia Pala, Tomasz Gondek, and Dawid Nidzworski.Read more
Sabina Żołędowska and Marcin Hałupka represented SensDx S.A. at the XXIV International Congress of the Nationwide Health Care System (OSOZ): Hospital Treatment – Second Health Care Line at OSOZ Platform on April 9th, 2019 at the International Congress Center in Katowice, Poland.Read more
On 18th June 2018 SensDx Digital Diagnostics presented itself at the prestigious Roche Innovation Summit in Basel. Among 150 individually invited companies from MedTech industry, SensDx got into Top 4 winning the category of Future Diagnostics in this way.Read more
An article, written by our SensDx Researchers, published in the prestigious Scientific Reports Nature magazine was chosen one of the top 100 in 2017!
Scientific Reportspublished more than 5000 chemistry papers in 2017, and so a position in the top 100 most highly read articles is an extraordinary achievement and great distinction for us.Read more
On November 29, 2017 SensDx won the international competition EIT Health InnoStars and became the first prize winner of € 30,000. Now he has a chance in the next prestigious competition. The SensDx’ s technology have been selected to showcase the product at the Start-Up Academy, Medtec Europe 2018.Read more
Neuca Med, subsidiary of NEUCA Group, leading supplier of health products and services in Poland, acquired 24,9% of SensDx sharesRead more
Alex Klarman joined the SensDx team and he is going to support the company in its international expansion, in particular in the field of Farming 4.0 (precision farming). Dr. Klarman is famous all over the world for his management activity and is the leading expert in the field of critical chain management as well as appreciated authority in the Theory of Constraints (TOC).Read more
On November 29, 2017 SensDx won the international “EIT Health InnoStars Awards” prize from the European Union’s Horizon 2020 research and innovation programme and received € 30,000. During the final in Naples, selected in two consecutive stages of this prestigious competition, innovative companies from Italy, Portugal, Greece, Hungary and Poland presented their technology, but SensDx was the best!Read more
SensDx participated in the MEDICA 2017 Healthcare Brokerage Event. This is an exclusive event for companies – part in the pilot program SME Instruments of the European Innovation Council (EIC), pertaining to the European Commission. SensDx was selected and invited to this global meeting of small and medium companies in the medical sector.Read more
The prestigious Scientifics Reports Nature magazine published an article, written by our SensDx Researchers. It is an online, open access journal from the publishers of Nature, which publishes scientifically valid primary research from all areas of the natural and clinical sciences.Read more
SensDx qualified to the third and final stage of the prestigious Innostars contest! At the end of November 8 innovative companies will present not only their technology, but also their business idea in front of experienced consultants.Read more
Asia Pacific MedTech Forum is one of the biggest and most important events in Asia for the MedTech sector. It took place from 7th to 9th November 2017 in the prestigious The Star Performing Arts Center in Singapure. This year the main them was ‘Transforming Healthcare through Innovation’.Read more
District Court for the Capital City of Warsaw in Warsaw
XIII Commercial Department of the National Court Register
Share capital: 100 000 zł (paid in full)
ul. Postępu 14B, 02-676 Warszawa
ul. Kampinoska 25, 80-180 Gdańsk
ul. Bierutowska 57-59, 51-317 Wrocław
(Wrocławski Park Biznesu 3)
ul. Nałęczowska 14, 20-701 Lublin
ul. Kampinoska 25, 80-180 Gdańsk
Poland, Czech Republic, Slovakia, Hungary